Meiban Corp Holdings, a global leader in contract manufacturing based in Singapore, today announced a strategic alliance with Planet Innovation (PI), an award-winning MedTech innovation and development company. The partnership aims to deliver comprehensive Contract Development and Manufacturing Organization (CDMO) services to the MedTech industry, spanning from early-stage innovation through to high-volume manufacturing.
This alliance enables clients to seamlessly transition from PI’s innovation, design, and early-stage manufacturing capabilities, located in Australia and the United States, to Meiban’s world-class, automated mass-manufacturing operations in Singapore and Malaysia.
In contrast to most CDMO providers who specialize in either front-end innovation or back-end manufacturing, Meiban and PI are bridging this critical gap in the MedTech ecosystem. The combined offering creates a unified, full-lifecycle solution for companies seeking speed, scale, and excellence in both development and production.
PI brings a team of over 300 professionals with deep healthcare expertise, advanced engineering skills, and a strong commercial focus. In addition to product design and engineering, PI operates flexible, made-to-order manufacturing facilities to support early market needs.
Meiban complements this by delivering high-volume, cost-effective manufacturing through 18 sites in Singapore and Malaysia. With vertically integrated capabilities including plastic injection molding, printed circuit board assembly, and full product assembly, Meiban leverages cutting-edge automation and precision systems to ensure quality and scalability.
As part of the alliance, Meiban will take an approximate 20% equity stake in Planet Innovation, reinforcing the long-term commitment between the two companies.
“Meiban has spent nearly four decades building a world-class contract manufacturing business and we are excited to announce this partnership with Planet Innovation. Our shared vision, to improve lives through the products we help bring to market, unites us. PI’s leadership in innovation is the perfect complement to Meiban’s strength in advanced, high-quality manufacturing,” said Cheok Kai Hock, CEO of Meiban Corp Holdings.
“This alliance combines PI’s innovation expertise with Meiban’s high-volume manufacturing excellence to create one of the most powerful and integrated CDMO offerings in the healthtech sector,” said Stuart Elliott, Co-founder and CEO of Planet Innovation. “It also provides our clients with the choice to manufacture in the USA, Asia, or Australia, depending on their strategic and commercial needs.”
This partnership positions both companies to better serve the evolving needs of the MedTech sector, delivering speed to market, reduced risk, and exceptional quality from concept through to commercialization.
Learn more about Meiban Corp Holdings here.
